Literature DB >> 22933867

The adaptive response (drug tolerance) helps to prevent drug-induced liver injury.

James H Lewis1.   

Abstract

Entities:  

Year:  2012        PMID： 22933867      PMCID： PMC3424431     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  11 in total

Review 1.  Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.

Authors:  Dean P Jones; John J Lemasters; Derick Han; Urs A Boelsterli; Neil Kaplowitz
Journal:  Mol Interv       Date:  2010-04

2.  'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective.

Authors:  James H Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-04       Impact factor: 2.890

Review 3.  Drug-related hepatotoxicity.

Authors:  Victor J Navarro; John R Senior
Journal:  N Engl J Med       Date:  2006-02-16       Impact factor: 91.245

Review 4.  Liver function tests and statins.

Authors:  Philippe J Zamor; Mark W Russo
Journal:  Curr Opin Cardiol       Date:  2011-07       Impact factor: 2.161

Review 5.  Predicting and preventing acute drug-induced liver injury: what's new in 2010?

Authors:  Gordon Liss; Sushil Rattan; James H Lewis
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-09       Impact factor: 4.481

Review 6.  Idiosyncratic drug hepatotoxicity.

Authors:  Neil Kaplowitz
Journal:  Nat Rev Drug Discov       Date:  2005-06       Impact factor: 84.694

7.  Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury.

Authors:  Mohammed Bourdi; Daniel P Eiras; Michael P Holt; Marie R Webster; Timothy P Reilly; Kevin D Welch; Lance R Pohl
Journal:  Chem Res Toxicol       Date:  2007-02       Impact factor: 3.739

8.  Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.

Authors:  Adrian Reuben; David G Koch; William M Lee
Journal:  Hepatology       Date:  2010-10-14       Impact factor: 17.425

Review 9.  Mechanisms of immune-mediated liver injury.

Authors:  David H Adams; Cynthia Ju; Shashi K Ramaiah; Jack Uetrecht; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2010-01-13       Impact factor: 4.849

10.  Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.

Authors:  P B Watkins; H J Zimmerman; M J Knapp; S I Gracon; K W Lewis
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272
View more
  7 in total

1.  Statin-induced cholestatic hepatitis: confirmed on rechallenge.

Authors:  Sam Kerzner; Nenita Irabagon; Charles Berkelhammer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-09

Review 2.  Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.

Authors:  Rashmi R Shah; Joel Morganroth; Devron R Shah
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.606

Review 3.  Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.

Authors:  Jonathan G Stine; James H Lewis
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-12-25       Impact factor: 3.869

4.  Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes.

Authors:  Andrew L Laccetti; Benjamin Garmezy; Lianchun Xiao; Minas Economides; Aradhana Venkatesan; Jianjun Gao; Eric Jonasch; Paul Corn; Amado Zurita-Saavedra; Landon C Brown; Chester Kao; Emily N Kinsey; Rajan T Gupta; Michael R Harrison; Andrew J Armstrong; Daniel J George; Nizar Tannir; Pavlos Msaouel; Amishi Shah; Tian Zhang; Matthew T Campbell
Journal:  Cancer Med       Date:  2021-03-01       Impact factor: 4.452

5.  Clinical implications of drug-induced liver injury in early-phase oncology clinical trials.

Authors:  Sebastian P Mondaca; Dazhi Liu; Jessica R Flynn; Sandy Badson; Stefan Hamaway; Mrinal M Gounder; Danny N Khalil; Alexander E Drilon; Bob T Li; Komal L Jhaveri; Alison M Schram; Katherine E Kargus; Mary Kate Kasler; Natalie M Blauvelt; Neil H Segal; Marinela Capanu; Margaret K Callahan; David M Hyman; Maya Gambarin-Gelwan; James J Harding
Journal:  Cancer       Date:  2020-08-18       Impact factor: 6.860

6.  Visualization of acute liver damage induced by cycloheximide in rats using PET with [(18)F]FEDAC, a radiotracer for translocator protein (18 kDa).

Authors:  Akiko Hatori; Joji Yui; Lin Xie; Tomoteru Yamasaki; Katsushi Kumata; Masayuki Fujinaga; Hidekatsu Wakizaka; Masanao Ogawa; Nobuki Nengaki; Kazunori Kawamura; Ming-Rong Zhang
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

7.  Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD.

Authors:  James H Lewis; Michel Jadoul; Geoffrey A Block; Melanie P Chin; Deborah A Ferguson; Angie Goldsberry; Colin J Meyer; Megan O'Grady; Pablo E Pergola; Scott A Reisman; W Christian Wigley; Glenn M Chertow
Journal:  Clin Transl Sci       Date:  2020-09-03       Impact factor: 4.689
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.